Yoram BenZeev - Elbit Systems Independent Director
| ESLT Stock | ILA 109,790 3,290 3.09% |
Director
Mr. Yoram BenZeev serves as Independent Director at Elbit Systems Ltd since 2014. He is a member of the Audit, Compensation and Financial Statements Review Committees and Chair of the Corporationrationrate Governance and Nominating Committee. His work experience includes the following roles Board member at several nonprofit organizations in Israel, Member of the Israel Ministry of Foreign Affairs Nomination Committee, Israel Ambassador to the Federal Republic of Germany, has held various senior roles in the MFA, including Deputy General Director, Head of North America Division and Senior Member of the Directorate, Israel Consul General to the West Coast of the United States, Political Advisor to Israel President, Special Coordinator to the Middle East Peace Process, Advisor to Prime Minister Ehud Barak for the Camp David Peace Conference and Chairman of the MFAs Steering Committee Foreign Service Strategic and Functional Planning and of the IsraelCanada Annual Strategic Forum since 2014.
| Age | 74 |
| Tenure | 11 years |
| Phone | (972) 4 8316659 |
| Web | www.elbitsystems.com |
Elbit Systems Management Efficiency
The company has return on total asset (ROA) of 0.0218 % which means that it generated a profit of $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0778 %, meaning that it generated $0.0778 on every $100 dollars invested by stockholders. Elbit Systems' management efficiency ratios could be used to measure how well Elbit Systems manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Perry Nisen | Teva Pharmaceutical Industries | 63 | |
| JeanMichel Halfon | Teva Pharmaceutical Industries | 67 | |
| Ronit Rokach | Bank Hapoalim | 61 | |
| Richard Kaplan | Bank Hapoalim | 63 | |
| Joseph Cowan | Nice | 70 | |
| Gerald Lieberman | Teva Pharmaceutical Industries | 72 | |
| Roberto Mignone | Teva Pharmaceutical Industries | 47 | |
| Nechemia Peres | Teva Pharmaceutical Industries | 60 | |
| Rosemary Crane | Teva Pharmaceutical Industries | 59 | |
| Ruben Krupik | Bank Hapoalim | 67 | |
| Zehava Simon | Nice | 60 | |
| Leo Apotheker | Nice | 65 | |
| Rimon BenShaoul | Nice | 74 | |
| Noam Hanegbi | Bank Hapoalim | 61 | |
| Moshe Koren | Bank Hapoalim | 81 | |
| Asaf Azulay | Bank Hapoalim | 35 | |
| Yocheved Dvir | Nice | 66 | |
| Yehoshua Ehrlich | Nice | 69 | |
| Dan Falk | Nice | 74 | |
| Dalya Lev | Bank Hapoalim | 71 | |
Management Performance
| Return On Equity | 0.0778 | |||
| Return On Asset | 0.0218 |
Elbit Systems Leadership Team
Elected by the shareholders, the Elbit Systems' board of directors comprises two types of representatives: Elbit Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elbit. The board's role is to monitor Elbit Systems' management team and ensure that shareholders' interests are well served. Elbit Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elbit Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bilha Shapira, Director | ||
| David Temin, Executive Vice President, Chief Compliance Officer and Senior Counsel | ||
| Raanan Horowitz, President & Chief Executive Officer of Elbit Systems of America (a subsidiary) | ||
| Dov Ninveh, Director | ||
| Rami Myerson, Director Relations | ||
| Yaacov Kagan, Ex CFO | ||
| Rina Baum, Director | ||
| Edgar Maimon, Executive Vice President and General Manager - EW and SIGINT Elisra Division | ||
| Ran Kril, Executive Vice President - International Marketing and Business Development | ||
| Zeev Gofer, Executive Vice President – Strategic and Business Development - North America | ||
| Michael Federmann, Chairman of the Board | ||
| Yehoshua Gleitman, External (Independent) Director | ||
| Jonathan Ariel, Executive Vice President & Chief Legal Officer | ||
| Yehoshua Yehuda, Executive Vice President-Chief Technology Officer | ||
| Joseph Gaspar, CFO, Principal Accounting Officer and Executive VP | ||
| Yoram BenZeev, Independent Director | ||
| Shelly Gordon, Executive Vice President of Human Resources | ||
| Yoram Shmuely, Executive Vice President and Co-General Manager - Aerospace Division | ||
| Ilan Pacholder, Executive Vice President - Mergers and Acquisitions, Offset and Financing | ||
| Yuli Tamir, Independent Director | ||
| Ehood Nisan, Independent Director | ||
| Yehuda Vered, Executive Vice President and General Manager – Land and C4I Division | ||
| Bezhalel Machlis, President, Chief Executive Officer | ||
| Elad Aharonson, Executive Vice President and General Manager - Unmanned Aircraft System (UAS) Division | ||
| David Federmann, Vice Chairman of the Board | ||
| Haim Delmar, Executive Vice President and General Manager - C4I and Cyber Division | ||
| Avi Mizrachi, Executive Vice President-Business Development-Israel & Southeast Asia | ||
| Yuval Ramon, Chief Operating Officer, Executive Vice President |
Elbit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elbit Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0778 | |||
| Return On Asset | 0.0218 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 29.61 B | |||
| Shares Outstanding | 44.34 M | |||
| Shares Owned By Insiders | 49.15 % | |||
| Shares Owned By Institutions | 21.74 % | |||
| Price To Book | 2.86 X | |||
| Price To Sales | 4.73 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Elbit Stock
When determining whether Elbit Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Elbit Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Elbit Systems Stock. Highlighted below are key reports to facilitate an investment decision about Elbit Systems Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elbit Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Elbit Stock refer to our How to Trade Elbit Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.